These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 4420394)

  • 1. Achieving a quality drug supply.
    Nelson G
    J Am Pharm Assoc; 1974 Oct; 14(10):548-9, 564. PubMed ID: 4420394
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pharmaceutical specialities: definitions and rules for manufacturing and marketing in Italy].
    Germani C; Montanari L; Petraroja A
    Boll Chim Farm; 1979 Mar; 118(3):135-43. PubMed ID: 475905
    [No Abstract]   [Full Text] [Related]  

  • 3. "Disclosure of retail prices for prescription drugs". Response of the American Pharmaceutical Association to the June 14, 1974, inquiry of the Federal Trade Commission.
    J Am Pharm Assoc; 1974 Oct; 14(10):538-42, 577-8. PubMed ID: 4418393
    [No Abstract]   [Full Text] [Related]  

  • 4. Securing the US pharmaceutical supply.
    Somberg JC
    Am J Ther; 2008; 15(3):197. PubMed ID: 18496255
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug product quality.
    Exp Med Surg; 1971; 29(1):135-44. PubMed ID: 5147595
    [No Abstract]   [Full Text] [Related]  

  • 6. US drug shortages are set to reach record high in 2011, report says.
    Tanne JH
    BMJ; 2011 Dec; 343():d8307. PubMed ID: 22194406
    [No Abstract]   [Full Text] [Related]  

  • 7. Drug standards laboratory enters second decade.
    Reese KM
    J Am Pharm Assoc; 1972 Jan; 12(1):16-20. PubMed ID: 5007258
    [No Abstract]   [Full Text] [Related]  

  • 8. The pharmacist's role in product selection.
    J Am Pharm Assoc; 1971 Apr; 11(4):181-99. PubMed ID: 5170866
    [No Abstract]   [Full Text] [Related]  

  • 9. 'Now it's their turn'.
    Silverman M
    J Am Pharm Assoc; 1971 Jul; 11(7):374-5 passim. PubMed ID: 5142131
    [No Abstract]   [Full Text] [Related]  

  • 10. [Essential drugs available to all].
    Bol Oficina Sanit Panam; 1992; 113(5-6):539-43. PubMed ID: 1296697
    [No Abstract]   [Full Text] [Related]  

  • 11. [Study group "Organisation and Economy of Drug Supply].
    Baumann D
    Pharm Prax; 1967; 1():21. PubMed ID: 5599823
    [No Abstract]   [Full Text] [Related]  

  • 12. American Pharmaceutical Association: reinbursement policy for prescription drugs.
    Apple WS
    J Am Pharm Assoc; 1974 May; 14(5):236-40. PubMed ID: 4831212
    [No Abstract]   [Full Text] [Related]  

  • 13. Toward more effective drug regulation.
    Schmidt AM
    FDA Consum; 1975 Dec-1976 Jan; 9(10):27-9. PubMed ID: 10316532
    [No Abstract]   [Full Text] [Related]  

  • 14. Extra-label drug use--pharmaceutical industry view.
    Welser JR
    J Am Vet Med Assoc; 1993 May; 202(10):1635-42;discussion 1654-8. PubMed ID: 8514571
    [No Abstract]   [Full Text] [Related]  

  • 15. Report suggests steps to improve safety of drug supply.
    Traynor K
    Am J Health Syst Pharm; 2011 Sep; 68(17):1570, 1574. PubMed ID: 21856799
    [No Abstract]   [Full Text] [Related]  

  • 16. Validation--how much can the world afford? Are we getting value for money?
    Anisfeld MH
    J Pharm Sci Technol; 1994; 48(1):45-8. PubMed ID: 8004419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fake pharmaceuticals: how they and relevant legislation or lack thereof contribute to consistently high and increasing drug prices.
    Moken MC
    Am J Law Med; 2003; 29(4):525-42. PubMed ID: 15119247
    [No Abstract]   [Full Text] [Related]  

  • 18. Enforcement of the current good manufacturing practices for solid oral dosage forms after United States v. Barr Laboratories.
    Jimenez FA
    Food Drug Law J; 1997; 52(1):67-82. PubMed ID: 10346711
    [No Abstract]   [Full Text] [Related]  

  • 19. Negotiating reality: the construction of enforceable pharmaceutical standards.
    Parrish RH
    Food Drug Law J; 2002; 57(3):457-74. PubMed ID: 12710406
    [No Abstract]   [Full Text] [Related]  

  • 20. AIHP Kremers Award Address 2006. Pharmacovigilance and the missing denominator: the changing context of pharmaceutical risk mitigation.
    Daemmrich A
    Pharm Hist; 2007; 49(2):61-75. PubMed ID: 18368740
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.